We provide you with 20 years of free, institutional-grade data for FOLD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of FOLD. Explore the full financial landscape of FOLD stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-31 | 1178879 | FOLD | 10-Q | Url |
| 2025-05-01 | 1178879 | FOLD | 10-Q | Url |
| 2025-02-19 | 1178879 | FOLD | 10-K | Url |
| 2024-11-06 | 1178879 | FOLD | 10-Q | Url |
| 2024-08-08 | 1178879 | FOLD | 10-Q | Url |
| 2024-05-09 | 1178879 | FOLD | 10-Q | Url |
| 2024-02-28 | 1178879 | FOLD | 10-K | Url |
| 2023-11-08 | 1178879 | FOLD | 10-Q | Url |
| 2023-08-08 | 1178879 | FOLD | 10-Q | Url |
| 2023-05-10 | 1178879 | FOLD | 10-Q | Url |
| 2023-03-01 | 1178879 | FOLD | 10-K | Url |
| 2022-11-07 | 1178879 | FOLD | 10-Q | Url |
| 2022-08-04 | 1178879 | FOLD | 10-Q | Url |
| 2022-05-10 | 1178879 | FOLD | 10-Q | Url |
| 2022-02-24 | 1178879 | FOLD | 10-K | Url |
| 2021-11-09 | 1178879 | FOLD | 10-Q | Url |
| 2021-08-05 | 1178879 | FOLD | 10-Q | Url |
| 2021-05-10 | 1178879 | FOLD | 10-Q | Url |
| 2021-03-01 | 1178879 | FOLD | 10-K | Url |
| 2020-11-05 | 1178879 | FOLD | 10-Q | Url |
| 2020-08-10 | 1178879 | FOLD | 10-Q | Url |
| 2020-05-07 | 1178879 | FOLD | 10-Q | Url |
| 2020-03-02 | 1178879 | FOLD | 10-K | Url |
| 2019-11-12 | 1178879 | FOLD | 10-Q | Url |
| 2019-08-08 | 1178879 | FOLD | 10-Q | Url |
| 2019-05-09 | 1178879 | FOLD | 10-Q | Url |
| 2019-02-28 | 1178879 | FOLD | 10-K | Url |
| 2018-11-05 | 1178879 | FOLD | 10-Q | Url |
| 2018-08-07 | 1178879 | FOLD | 10-Q | Url |
| 2018-05-09 | 1178879 | FOLD | 10-Q | Url |
| 2018-03-01 | 1178879 | FOLD | 10-K | Url |
| 2017-11-08 | 1178879 | FOLD | 10-Q | Url |
| 2017-08-07 | 1178879 | FOLD | 10-Q | Url |
| 2017-05-09 | 1178879 | FOLD | 10-Q | Url |
| 2017-03-01 | 1178879 | FOLD | 10-K | Url |
| 2016-11-07 | 1178879 | FOLD | 10-Q | Url |
| 2016-08-09 | 1178879 | FOLD | 10-Q | Url |
| 2016-05-03 | 1178879 | FOLD | 10-Q | Url |
| 2016-02-29 | 1178879 | FOLD | 10-K | Url |
| 2015-11-04 | 1178879 | FOLD | 10-Q | Url |
| 2015-08-05 | 1178879 | FOLD | 10-Q | Url |
| 2015-05-05 | 1178879 | FOLD | 10-Q | Url |
| 2015-03-03 | 1178879 | FOLD | 10-K | Url |
| 2014-11-06 | 1178879 | FOLD | 10-Q | Url |
| 2014-08-07 | 1178879 | FOLD | 10-Q | Url |
| 2014-05-05 | 1178879 | FOLD | 10-Q | Url |
| 2014-03-03 | 1178879 | FOLD | 10-K | Url |
| 2013-11-12 | 1178879 | FOLD | 10-Q | Url |
| 2013-08-07 | 1178879 | FOLD | 10-Q | Url |
| 2013-05-09 | 1178879 | FOLD | 10-Q | Url |
| 2013-03-13 | 1178879 | FOLD | 10-K | Url |
| 2012-11-06 | 1178879 | FOLD | 10-Q | Url |
| 2012-08-08 | 1178879 | FOLD | 10-Q | Url |
| 2012-05-11 | 1178879 | FOLD | 10-Q | Url |
| 2012-02-28 | 1178879 | FOLD | 10-K | Url |
| 2011-11-02 | 1178879 | FOLD | 10-Q | Url |
| 2011-08-11 | 1178879 | FOLD | 10-Q | Url |
| 2011-05-05 | 1178879 | FOLD | 10-Q | Url |
| 2011-03-04 | 1178879 | FOLD | 10-K | Url |
| 2010-11-09 | 1178879 | FOLD | 10-Q | Url |
| 2010-08-06 | 1178879 | FOLD | 10-Q | Url |
| 2010-05-07 | 1178879 | FOLD | 10-Q | Url |
| 2010-03-10 | 1178879 | FOLD | 10-K | Url |
| 2009-11-04 | 1178879 | FOLD | 10-Q | Url |
| 2009-08-06 | 1178879 | FOLD | 10-Q | Url |
| 2009-05-08 | 1178879 | FOLD | 10-Q | Url |
| 2009-02-06 | 1178879 | FOLD | 10-K | Url |
| 2008-11-04 | 1178879 | FOLD | 10-Q | Url |
| 2008-08-08 | 1178879 | FOLD | 10-Q | Url |
| 2008-05-14 | 1178879 | FOLD | 10-Q | Url |
| 2008-02-08 | 1178879 | FOLD | 10-K | Url |
| 2007-10-31 | 1178879 | FOLD | 10-Q | Url |
| 2007-08-07 | 1178879 | FOLD | 10-Q | Url |
| 2007-03-30 | 1178879 | FOLD | S-1 | Url |
| 2006-05-17 | 1178879 | FOLD | S-1 | Url |
Amicus Therapeutics, Inc(NASDAQ:FOLD) 
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed dia...
Website: http://www.amicusrx.com
Founded: 2002
Full Time Employees: 584
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about FOLD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.